1171 related articles for article (PubMed ID: 18644444)
21. Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies.
Sintov AC; Levy HV; Botner S
J Control Release; 2010 Dec; 148(2):168-76. PubMed ID: 20709120
[TBL] [Abstract][Full Text] [Related]
22. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
23. Novel fibrillar insulin formulations for oral administration: Formulation and in vivo studies in diabetic mice.
Dekel Y; Glucksam Y; Margalit R
J Control Release; 2010 Apr; 143(1):128-35. PubMed ID: 20043960
[TBL] [Abstract][Full Text] [Related]
24. Influence of magnesium stearate on the physicochemical and pharmacodynamic characteristics of insulin-loaded Eudragit entrapped mucoadhesive microspheres.
Momoh MA; Kenechukwu FC; Nnamani PO; Umetiti JC
Drug Deliv; 2015; 22(6):837-48. PubMed ID: 24670092
[TBL] [Abstract][Full Text] [Related]
25. Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate/chitosan nanoparticles.
Zhang N; Li J; Jiang W; Ren C; Li J; Xin J; Li K
Int J Pharm; 2010 Jun; 393(1-2):212-8. PubMed ID: 20394813
[TBL] [Abstract][Full Text] [Related]
26. Alginate microparticles prepared by spray-coagulation method: preparation, drug loading and release characterization.
Tu J; Bolla S; Barr J; Miedema J; Li X; Jasti B
Int J Pharm; 2005 Oct; 303(1-2):171-81. PubMed ID: 16129575
[TBL] [Abstract][Full Text] [Related]
27. Entrapment of andrographolide in cross-linked alginate pellets: I. Formulation and evaluation of associated release kinetics.
Shariff A; PK M; KLK P; M M
Pak J Pharm Sci; 2007 Jan; 20(1):1-9. PubMed ID: 17337420
[TBL] [Abstract][Full Text] [Related]
28. Development and in vitro evaluation of alginate gel-encapsulated, chitosan-coated ceramic nanocores for oral delivery of enzyme.
Rawat M; Singh D; Saraf S; Saraf S
Drug Dev Ind Pharm; 2008 Feb; 34(2):181-8. PubMed ID: 18302037
[TBL] [Abstract][Full Text] [Related]
29. Oral peptide delivery: in-vitro evaluation of thiolated alginate/poly(acrylic acid) microparticles.
Greimel A; Werle M; Bernkop-Schnürch A
J Pharm Pharmacol; 2007 Sep; 59(9):1191-8. PubMed ID: 17883889
[TBL] [Abstract][Full Text] [Related]
30. Formulation and characterization of an oily-based system for oral delivery of insulin.
Elsayed A; Remawi MA; Qinna N; Farouk A; Badwan A
Eur J Pharm Biopharm; 2009 Oct; 73(2):269-79. PubMed ID: 19508890
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of furosemide-loaded alginate microspheres prepared by ionotropic external gelation technique.
Das MK; Senapati PC
Acta Pol Pharm; 2007; 64(3):253-62. PubMed ID: 17695149
[TBL] [Abstract][Full Text] [Related]
32. Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients.
Razavi Rohani SS; Abnous K; Tafaghodi M
Int J Pharm; 2014 Apr; 465(1-2):464-78. PubMed ID: 24560646
[TBL] [Abstract][Full Text] [Related]
33. Alginate/chitosan microparticles for tamoxifen delivery to the lymphatic system.
Coppi G; Iannuccelli V
Int J Pharm; 2009 Feb; 367(1-2):127-32. PubMed ID: 18940240
[TBL] [Abstract][Full Text] [Related]
34. Biodegradable alginate microparticles developed by electrohydrodynamic spraying techniques for oral delivery of protein.
Suksamran T; Opanasopit P; Rojanarata T; Ngawhirunpat T; Ruktanonchai U; Supaphol P
J Microencapsul; 2009 Nov; 26(7):563-70. PubMed ID: 19839791
[TBL] [Abstract][Full Text] [Related]
35. Fabrication of microparticle protein delivery systems based on calcium alginate.
Yu CY; Jia LH; Cheng SX; Zhang XZ; Zhuo RX
J Microencapsul; 2010; 27(2):171-7. PubMed ID: 19538029
[TBL] [Abstract][Full Text] [Related]
36. Novel composite microparticles for protein stabilization and delivery.
Schoubben A; Blasi P; Giovagnoli S; Perioli L; Rossi C; Ricci M
Eur J Pharm Sci; 2009 Feb; 36(2-3):226-34. PubMed ID: 18950709
[TBL] [Abstract][Full Text] [Related]
37. Insulin-loaded alginic acid nanoparticles for sublingual delivery.
Patil NH; Devarajan PV
Drug Deliv; 2016; 23(2):429-36. PubMed ID: 24901208
[TBL] [Abstract][Full Text] [Related]
38. Development and characterization of nanoparticles of glibenclamide by solvent displacement method.
Dora CP; Singh SK; Kumar S; Datusalia AK; Deep A
Acta Pol Pharm; 2010; 67(3):283-90. PubMed ID: 20524431
[TBL] [Abstract][Full Text] [Related]
39. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
[TBL] [Abstract][Full Text] [Related]
40. Coated whey protein/alginate microparticles as oral controlled delivery systems for probiotic yeast.
Hébrard G; Hoffart V; Beyssac E; Cardot JM; Alric M; Subirade M
J Microencapsul; 2010; 27(4):292-302. PubMed ID: 20163284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
